Literature DB >> 20100161

Hypertriglyceridemia: An underdiagnosed side effect of Capecitabine chemotherapy.

George S Orphanos1, Nicos G Stavrou, Michalis K Picolos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20100161     DOI： 10.3109/02841860903373708

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  3 in total

1.  The frequency and severity of capecitabine-induced hypertriglyceridaemia in routine clinical practice: a prospective study.

Authors:  C O Michie; M Sakala; I Rivans; M W J Strachan; S Clive
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

2.  Reversible severe fatty liver induced by capecitabine: A case report.

Authors:  Yiyan Jiang; Qiancheng He; Suxia Li; Chang Shi; Xiaolei Yang
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

3.  Capecitabine-induced hypertriglyceridemia: a rare but clinically relevant treatment-related adverse event.

Authors:  An Uche; Ritika Vankina; Jun Gong; May Cho; James J Yeh; Phyllis Kim; Kathy Pan
Journal:  J Gastrointest Oncol       Date:  2018-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.